Precoccious puberty during outpatient pamidronate therapy in type I Osteogenesis Imperfecta.

被引：0
|
作者：
Markello, TC
Boston, R
Steiner, R
机构：
[1] Samaritan Hlth Serv, Dept Pediat, Lebanon, OR USA
[2] Oregon Hlth Sci Univ, Portland, OR 97201 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2002年 / 71卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
2400
引用
收藏
页码：579 / 579
页数：1
相关论文
共 50 条
  • [41] Effect of 3 years of pamidronate on the functional, radiographic, densitometric and biochemical outcomes of infants with severe osteogenesis imperfecta.
    Munns, CFJ
    Rauch, F
    Glorieux, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S464 - S464
  • [42] Bone mineral density assessed by DEXA does not improve spontaneously during puberty in girls with untreated mild osteogenesis imperfecta.
    Wenkert, D
    Podgornik, MN
    McAlister, WH
    Whyte, WH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S384 - S384
  • [43] Involvement of abnormal type V collagen in a family with recurrent osteogenesis imperfecta.
    Ausems, MGEM
    Pals, G
    Beemer, FA
    Nicholls, AC
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A408 - A408
  • [44] Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta
    Lowing, Kristina
    Astrom, Eva
    Oscarsson, Katarina Allbrink
    Soderhall, Stefan
    Eliasson, Ann-Christin
    ACTA PAEDIATRICA, 2007, 96 (08) : 1180 - 1183
  • [45] Cyclical pamidronate treatment does not affect bone mineralization density distribution in children suffering from osteogenesis imperfecta.
    Roschger, P
    Weber, M
    Fratzl-Zelman, N
    Fratzl, P
    Klaushofer, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S411 - S411
  • [46] Hypercalciuria in osteogenesis imperfecta type I
    Ammenti, A
    Nitsch, M
    KLINISCHE PADIATRIE, 2003, 215 (05): : 283 - 285
  • [47] IV bisphosphonate therapy in children under 36 months of age with osteogenesis imperfecta.
    DiMeglio, LA
    Ford, L
    McClintock, C
    Peacock, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S382 - S382
  • [48] Reshaping of Vertebrae during Treatment with Neridronate or Pamidronate in Children with Osteogenesis Imperfecta
    Semler, O.
    Beccard, R.
    Palmisano, D.
    Demant, A.
    Fricke, O.
    Schoenau, E.
    Koerber, F.
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 76 (05): : 321 - 327
  • [49] Osteoporosis Improved by Romosozumab Therapy in a Patient With Type I Osteogenesis Imperfecta
    Dattagupta, Antara
    Petak, Steven
    AACE CLINICAL CASE REPORTS, 2023, 9 (06): : 209 - 212
  • [50] Improved growth during the first year of monthly intravenous pamidronate therapy in prepubertal patients with osteogenesis imperfecta
    Heino, Terhi J.
    Astrom, Eva
    Savendahl, Lars
    Soderhall, Stefan
    HORMONE RESEARCH, 2009, 72 : 223 - 223
12345